Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons

Cell Death and Differentiation

Volumn 5, Issue 10, 1998, Pages 876-883

  Gill, Jagjit S ^a   Windebank, Anthony J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Apoptosis; Ceramide; Chemotherapy; Dorsal root ganglion; Peripheral neuropathy

Indexed keywords

CERAMIDE; GANGLIOSIDE; GLYCOLIPID; SURAMIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CYTOTOXICITY; DRUG ACCUMULATION; DRUG ACTIVITY; ELECTRON MICROSCOPY; EMBRYO; GEL ELECTROPHORESIS; LIPID METABOLISM; LIPID TRANSPORT; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SPINAL GANGLION;

ANIMALIA;

EID: 0031788607     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400410     Document Type: Article

References (47)

1. Akanji MA (1988) Rat kidney lysosomal membrane damage induced by suramin in vitro and in vivo. Pharmacol. Toxicol. 62: 318-321
2. Batistatou A and Greene LA (1993) Internucleosomal DNA cleavage and neuronal cell survival/death. J. Cell Biol. 122. 523-532
3. Betsholtz C, Johnsson A, Heldin C-H and Westermark B (1986) Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. Proc. Natl Acad. Sci. USA 83 6440-6444
4. Bielawska A, Crane HM, Liotta D, Obeid LM and Hannun YA (1993) Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide J Biol. Chem. 268: 26226-26232
5. Bornstein MB (1958) Reconstituted rat-tail collagen used as substrate for tissue cultures on coverslips in Maximow slides and roller tubes. Lab. Invest. 7:134-137
6. Broder S, Collins JM, Markham PD, Redfield RR, Hoth DF, Groopman JE, Gallo RC, Yarchoan R, Lane HC, Klecker RW, Mitsuya H, Gelmann E, Resnick L, Myers CE and Fauci AS (1985) Effects of suramin on HTLV-III/ LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo. Lancet 2: 627-630
7. Brugg B, Michel PP, Agid Y and Ruberg M (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66: 733-739
8. Buys CHCM, Bouma JMW, Gruber M and Wisse E (1978) Induction of fysosomal storage by suramin Naunyn-Schmiedeberg's Arch. Pharmacol 304: 183-190
9. Cardinali M, Sartor O and Robbins KC (1992) Suramin, an expenmental chemotherapeutic drug, activates the receptor for epidermal growth factor and promotes growth of certain malignant cells. J. Clin. Invest. 89: 1242-1247
10. Coffey RJ, Leof EB, Shipley GD and Moses HL (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells J. Cell. Physiol. 132: 143-148
11. Constantopoulos G, Rees S, Cragg BG, Barranger JA and Brady RO (1981) Effect of suramin on the activities of degradative enzymes of sphingolipids in rats. Res Commun. Chem. Pathol Pharmacol. 32: 87-97
12. Deckwerth TL and Johnson EM, Jr (1993) Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor J. Cell Biol. 123. 1207-1222
13. Edwards SN and Tolkovsky AM (1994) Characterization of apoptosis in cultured rat sympathetic neurons after nerve growth factor withdrawal J Cell Biol. 124:537-546
14. Gansler T, Vaghmar N, Olson JJ and Graham SD (1992) Suramin inhibits growth factor binding and proliferation by urothelial carcinoma cell cultures. J. Urol. 148: 910-914
15. Gill JS, Hobday KL and Windebank AJ (1995) Mechanism of suramin toxicity in stable myelinating dorsal root ganglion cultures. Exp. Neurol. 133: 113-124
16. Gill JS, Connolly DC, McManus MJ, Maihle NJ and Windebank AJ (1996) Suramin induces phosphorylation of the high-affinity nerve growth factor receptor in PC12 cells and dorsal root ganglion neurons. J. Neurochem. 66: 963-972
17. Gill JS and Windebank AJ (1997) Role of ceramide in suramin-induced cancer cell death Cancer Lett. 119: 169-176
18. Gill JS and Windebank AJ (1998) Activation of the high affinity nerve growth factor receptor by two polyanionic chemotherapeutic agents: role in drug induced neurotoxicity. J. Neurooncol. (in press)
19. Gu M, Kerwin JL, Watts JD and Aebersold R (1997) Ceramide profiling of complex lipid mixtures by electrospray lonization mass spectrometry. Anal. Biochem. 244: 347-356
20. Hannun YA and Linardic CM (1993) Sphingolipid breakdown products, antiproliferative and tumor-suppressor lipids Biochim Biophys. Acta 1154: 223-236
21. Hannun YA and Obedi LM (1995) Ceramide an intracellular signal for apoptosis Trends Biochem. Sci 20 73-77
22. Hawking F (1978) Suramin: with special reference to onchocerciasis Adv. Pharmacol. Chemother. 15: 289-322
23. Hosang M (1985) Suramin binds to platelet-derived growth factor and inhibits its biological activity J. Cell. Biochem. 29: 265-273
24. Kim JH, Sherwood ER, Sutkowski DM, Lee C and Kozlowski JM (1991) Inhibition of prostatic tumor cell proliferation by suramin alterations in TGF alpha-mediated autocrine growth regulation and cell cycle distribution. J Urol. 146 171-176
25. LaRocca RV, Stein CA, Danesi R and Myers CE (1990a) Suramin, a novel antitumor compound J. Steroid Biochem. Mol. Biol. 37: 893-898
26. LaRocca RV, Stein CA, Myers CE, Dalakas M and McAtee N (1989) Suramin induced acute polyneuropathy. Proc. Annu. Meet, Am. Soc. Clin. Oncol. 8: 71 (Abstract)
27. LaRocca RV, Meer J, Gilliatt RW, Stein CA, Cassidy J, Myers CE and Dalakas MC (1990b) Suramin-induced polyneuropathy Neurology 40. 954-960
28. LaRocca RV, Cooper MR, Uhnch M, Danesi R, Walther MM, Linehan WM and Myers CE (1991) Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation. Urol. Clin North Am. 18: 123-129
29. Li R and Ladisch S (1997) Inhibition of endogenous ganglioside synthesis does not block neunte formation by retinoic acid-treated neuroblastoma cells J Biol Chem 272: 1349-1354
30. Mahoney CW, Azzi A and Huang K-P (1990) Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C Differential activation and inhibition of protein kinase C isozymes. J. Biol Chem. 265: 5424-5428
31. Obeid LM, Linardic CM, Karolak LA and Hannun YA (1993) Programmed cell death induced by ceramide. Science 259: 1769-1771
32. Piqueras B, Autran B, Debre P and Gorochov G (1996) Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. Biotechniques 20: 634-640
33. Pittman RN, Wang S, DiBenedetto AJ and Mills JC (1993) A system for characterizing cellular and molecular events in programmed neuronal cell death. J. Neurosci 13: 3669-3680
34. Pollak M and Richard M (1990) Suramm blockade of insulinlike growth factor I-stimulated proliferation of human osteosarcoma cells [published erratum appears in J Natl Cancer Inst 1990 Sept 19; 82: 1510]. J Natl Cancer Inst. 82: 1349-1352
35. Preiss JE, Loomis CR, Bell RM and Niedel JE (1987) Quantitative measurement of sn-1,2-diacylglycerols. Methods Enzymol 141: 294-300
36. Rees S (1978) Membranous neuronal and neuroglial inclusions produced by mtracerebral injection of suramin. J. Neurol Sci. 36 97-109
37. Rees S, Constantopoulos G, Barranger JA and Brady RO (1982) Organomegaly and histopathology in an animal model of mucopolysaccharidosis induced by suramin. Naunyn Schmiedebergs Arch. Pharmacol. 319: 262-270
38. Russell JW and Windebank AJ (1993) Electrophysiological and pathological characteristics of suramin-induced neuropathy Neurology 43: A174(Abstract)
39. Sartor O, McLellan CA, Myers CE and Bomer MM (1992) Suramin rapidly alters cellular tyrosine phosphorylation in prostate cancer cell lines. J Clin. Invest. 90: 2166-2174
40. Sjölund M and Thyberg J (1939) Suramin inhibits binding and degradation of platelet-derived growth factor in arterial smooth muscle cells but does not interfere with autocrine stimulation of DNA synthesis. Cell Tissue Res. 256: 35-43
41. Stein CA, LaRocca RV, Thomas R, McAtee N and Myers CE (1988) Suramin: an active agent in metastatic adrenocortical carcinoma. Proc. Annu. Meet. Am. Soc. Clin. Oncol. 7: A345(Abstract)
42. 125I-epidermal growth factor binding to human meningiomas Cell Mol Neurobiol. 13. 665-675
43. 125I-insulin-like growth factor-I binding to human meningiomas and on proliferation of meningioma cells. J. Neurosurg. 80: 502-509
44. Watts JD, Gu M, Polverino AJ, Patterson SD and Aebersold R (1997) Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc. Natl Acad Sci. USA 94: 7292-7296
45. Wiesner D and Dawson G (1996) PCD in neuronal cells is dependent on the formation of ceramide. J. Neurochem. 66. S25(Abstract)
46. Wyllie AH, Kerr JF and Currie AR (1980) Cell death: the significance of apoptosis Int Rev.Cytol. 68: 251-306
47. Wyllie AH (1985) The biology of cell death in tumours. Anticancer Res. 5 .131-136